Related Experiment Video

Updated: Oct 14, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.1K

Moving Ru polypyridyl complexes beyond cytotoxic activity towards metastasis inhibition

Małgorzata Brindell1, Ilona Gurgul1, Ewelina Janczy-Cempa1

  • 1Department of Inorganic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland.

Journal of Inorganic Biochemistry
|November 6, 2021
PubMed

Insights

Ruthenium polypyridyl complexes show promise as antimetastatic agents by inhibiting cancer cell migration, invasion, and adhesion. Research is identifying specific target proteins responsible for this antimetastatic activity.

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Biochemistry

Background:

  • Ruthenium polypyridyl complexes are explored for anticancer properties.
  • Metastasis poses a significant threat, driving research into metastasis inhibitors.

Purpose of the Study:

  • To review recent advancements in ruthenium polypyridyl complexes as antimetastatic agents.
  • To identify target proteins involved in the antimetastatic activity of these complexes.

Main Methods:

  • Literature review focusing on antimetastasis research of Ru polypyridyl complexes.
  • Analysis of studies investigating effects on cell migration, invasion, and adhesion.

Main Results:

  • Ruthenium polypyridyl complexes demonstrate potential in inhibiting key metastatic processes.
  • Identification of specific target proteins is crucial for understanding their antimetastatic mechanisms.

Conclusions:

  • Ruthenium polypyridyl complexes are promising candidates for antimetastatic therapies.
  • Further research into target proteins will refine their therapeutic application against metastasis.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.7K
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.0K

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K